Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://toad.social/users/minorusaba/statuses/112856485632229479">Minoru Saba (minorusaba@toad.social)'s status on Saturday, 27-Jul-2024 13:08:31 JST</a><a href="https://toad.social/@minorusaba" title="minorusaba@toad.social"><img src="https://gnusocial.jp/avatar/139443-48-20230930221108.webp" width="48" height="48" alt="Minoru Saba" style="position: absolute; left: 0; top: 0;">Minoru Saba</a></section><article><p>"A clinical study of artificial red blood cells that can be stored for transfusions in times of emergency will begin in <a href="https://toad.social/tags/Japan" rel="tag">#Japan</a>  by next March, according to Nara Medical University"<br><a href="https://mainichi.jp/english/articles/20240727/p2g/00m/0sc/013000c" rel="nofollow noreferrer">https://mainichi.jp/english/articles/20240727/p2g/00m/0sc/013000c</a></p><p>"Hiromi Sakai (Nara Medical University) developed a...PEG stabilized, lipid vesicle encapsulated hemoglobin product"<br>"Some participants [in a phase I clinical trial] experienced adverse effects..., but they were tolerable and temporary"<br>(18 Jan 2023)<br><a href="https://www.drugdiscoverynews.com/making-blood-in-the-lab-15596" rel="nofollow noreferrer">https://www.drugdiscoverynews.com/making-blood-in-the-lab-15596</a><br><a href="https://toad.social/tags/ArtificialBlood" rel="tag">#ArtificialBlood</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3435268#notice-6753964">In conversation</a><time datetime="2024-07-27T13:08:31+09:00" title="Saturday, 27-Jul-2024 13:08:31 JST">about 4 months ago</time> <span>from <span><a href="https://toad.social/@minorusaba/112856485632229479" rel="external" title="Sent from toad.social via ActivityPub">toad.social</a></span></span><a href="https://toad.social/@minorusaba/112856485632229479">permalink</a><h4>Attachments</h4><ol><li><article><header><div>Domain not in remote thumbnail source whitelist: cdn.mainichi.jp</div><h5><a href="https://mainichi.jp/english/articles/20240727/p2g/00m/0sc/013000c">Clinical trial on artificial blood cells to begin in Japan - The Mainichi</a></h5><div> from <span>https://www.facebook.com/themainichi/</span></div></header><div>NARA (Kyodo) -- A clinical study of artificial red blood cells that can be stored for transfusions in times of emergency will begin in Japan by next M</div><footer></footer></article></li><li><article><header><div>Domain not in remote thumbnail source whitelist: cdn.drugdiscoverynews.com</div><h5><a href="https://www.drugdiscoverynews.com/making-blood-in-the-lab-15596">Making blood in the lab</a></h5><div></div></header><div>Facing donor shortages and storage limitations, researchers are developing synthetic red blood cells, platelets, and plasma and combining them into artificial blood.</div><footer></footer></article></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Minoru Saba (minorusaba@toad.social)'s status on Saturday, 27-Jul-2024 13:08:31 JST Minoru Saba
"A clinical study of artificial red blood cells that can be stored for transfusions in times of emergency will begin in #Japan by next March, according to Nara Medical University"
https://mainichi.jp/english/articles/20240727/p2g/00m/0sc/013000c
"Hiromi Sakai (Nara Medical University) developed a...PEG stabilized, lipid vesicle encapsulated hemoglobin product"
"Some participants [in a phase I clinical trial] experienced adverse effects..., but they were tolerable and temporary"
(18 Jan 2023)
https://www.drugdiscoverynews.com/making-blood-in-the-lab-15596
#ArtificialBlood
In conversationabout 4 months ago from toad.socialpermalink
Attachments
1. Domain not in remote thumbnail source whitelist: cdn.mainichi.jp
  Clinical trial on artificial blood cells to begin in Japan - The Mainichi
  from https://www.facebook.com/themainichi/
  NARA (Kyodo) -- A clinical study of artificial red blood cells that can be stored for transfusions in times of emergency will begin in Japan by next M
2. Domain not in remote thumbnail source whitelist: cdn.drugdiscoverynews.com
  Making blood in the lab
  Facing donor shortages and storage limitations, researchers are developing synthetic red blood cells, platelets, and plasma and combining them into artificial blood.

Public

Embed Notice

HTML Code

Corresponding Notice